春立医疗(01858)公布2024年业绩，营业收入约8.06亿元，同比下降33.32%。毛利为约5.37亿元，同比下降38.7%。归属于母公司股东的净利润约1.25亿元，同比减少约55%。基本每股收益0.33元，每10股派发末期股息0.49元

公告称，业绩下滑主要是由于集采政策持续深化，公司对国家集中带量采购政策积极贯彻执行，相关产品价格下降，毛利率下降。为应对行业政策的变化，保障集采中标产品的稳定供应，公司对集采实施前的渠道库存进行价格调整，导致公司营业总收入减少。

海量资讯、精准解读，尽在新浪财经APP

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.